← Leaderboards
Patrick C Roche
Mayo Clinic Coll Of Medicine, Rochester
$687,974
Attributed
$687,974
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$687,974 · 3
By mechanism
P30$372,919 · 1
U10$157,740 · 1
U54$157,315 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Esteban Celis$7,550,811
- Jan C Buckner$13,181,861
- Robert B. Jenkins$6,438,057
- Alex A Adjei$13,436,633
- Lieping Chen$19,852,609
Others in their field
Top investigators on “Neoplasm /Cancer”
- Charles A Coltman · Southwest Oncology Group$175,115,529
- Gregory H Reaman · National Childhood Cancer Foundation$143,691,240
- Norman Wolmark · Nsabp Foundation, Inc.$129,902,100
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Bruce J Hillman · American College Of Radiology$89,322,170
- Richard L Schilsky · University Of Chicago$73,198,934
Research focus
Neoplasm /CancerCancer Registry /ResourceOncologyTissue Resource /RegistryBiomedical FacilityPrognosisDiagnosis Design /EvaluationMicroarray TechnologyNeoplasm /Cancer DiagnosisTumor AntigensNeoplasm /Cancer GeneticsNeoplasm /Cancer ImmunologyClinical ResearchHuman SubjectOvaryPolymerase Chain ReactionProtein Structure FunctionReceptor BindingSite Directed MutagenesisSynthetic PeptideMessenger RnaChemical Structure FunctionChorionic GonadotropinComplementary Dna
Grant awards (9)
TRANSLATIONAL RESEARCH$78,870
U10 · FY2002 · CA
TRANSLATIONAL RESEARCH$78,870
U10 · FY2002 · CA
Core--Tissue acquistion$72,259
P30 · FY2002 · CA
Core--Tissue acquistion$228,401
P30 · FY2001 · CA
Core--Tissue acquistion$72,259
P30 · FY2001 · CA
TRANSLATIONAL RESEARCH$0
U10 · FY2001 · CA
STRUCTURE/FUNCTION OF GONADOTROPINS AND RECEPTORS$157,315
U54 · FY2000 · HD
Core--Tissue acquistion$0
P30 · FY2000 · CA
Core--Tissue acquistion$0
P30 · FY2000 · CA